Although FOXO4 down-regulation is reported to correlate with reduced prostate cancer metastasis-free survival, conversely FOXO4 knockdown in LNCaP cells can increase metastatic potential [163]. The gene discussed is FOXO4; the disease is prostate carcinoma.